article thumbnail

Gene variants help explain connection between skin disorder and food allergy risk

Scienmag

Discovery could lead to new screening tests and potential treatments Credit: Cincinnati Children’s Two common variants in the KIF3A gene increase the risk of young children having a dysfunctional skin barrier and developing the skin condition atopic dermatitis.

article thumbnail

RVAC and University of Pennsylvania to develop mRNA vaccines

Pharmaceutical Technology

The partnership will focus on developing potential new vaccines to treat certain selected autoimmune indications, as well as food allergies. RVAC Medicines chief scientific officer Dr Jason Zhang said: “We are very glad to work with Dr Weissman on potential mRNA treatment approaches for a broad spectrum of allergy and autoimmune diseases.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

GreenLight and US NIH partner to develop Covid-19 vaccine for variants

Pharmaceutical Technology

The company will jointly design and analyse messenger ribonucleic acid (mRNA) Covid-19 vaccines in partnership with the NIH unit National Institute of Allergy and Infectious Diseases’ Vaccine Research Center (VRC). Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

article thumbnail

Airways of individuals with asthma found to have higher expression of genes that amplify inflammation

Medical Xpress

The strongest risk factor for developing asthma is the presence of allergies, but it's unclear why only some individuals with allergies go on to develop asthma.

article thumbnail

High levels of lipids in blood found to protect against allergies

Medical Xpress

These lipids cause genes that play a key role in allergic reactions to be less active. People with relatively high levels of lipids in their blood are less likely to develop allergic conditions such as eczema and asthma.

article thumbnail

Cellular benefits of gene therapy seen decades after treatment

Scienmag

An international collaboration between Great Ormond Street Hospital, the UCL GOS Institute for Child Health and Harvard Medical School has shown that the beneficial effects of gene therapy can be seen decades after the transplanted blood stem cells has been cleared by the body.

article thumbnail

Gene therapy offers potential cure to children born without an immune system

Scienmag

Study shows treatment developed by international team restored immune function in more than 95% of patients in three clinical trials Credit: Ann Johansson/UCLA Broad Stem Cell Research Center An experimental form of gene therapy developed by a team of researchers from UCLA and Great Ormond Street Hospital in London has successfully treated 48 of 50 (..)